IKK inhibition increases bortezomib effectiveness in ovarian cancer

Ovarian cancer is associated with increased expression of the pro-angiogenic chemokine interleukin-8 (IL-8, CXCL8), which induces tumor cell proliferation, angiogenesis, and metastasis. Even though bortezomib (BZ) has shown remarkable anti-tumor activity in hematological malignancies, it has been le...

Descripción completa

Detalles Bibliográficos
Autores principales: Singha, Bipradeb, Gatla, Himavanth Reddy, Phyo, Sai, Patel, Atish, Chen, Zhe-Sheng, Vancurova, Ivana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694906/
https://www.ncbi.nlm.nih.gov/pubmed/26267322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694906/
https://www.ncbi.nlm.nih.gov/pubmed/26267322

Ejemplares similares